Showing results (231-240 of 249) with videos related to

Sort By:
Pageof 25
Human Immunology|November 26, 2008
A polymorphism in the interleukin-10 promoter affects the course of disease in patients with clear-cell renal carcinomaJosé María Romero, Pablo Sáenz-López, José Manuel Cózar, et al.
International Journal of Molecular Sciences|July 24, 2021
Tumor Escape Phenotype in Bladder Cancer Is Associated with Loss of HLA Class I Expression, T-Cell Exclusion and Stromal ChangesHernani Gil-Julio, Francisco Perea, Antonio Rodriguez-Nicolas, et al.
Frontiers in Immunology|March 31, 2023
First in man study: Bcl-Xl_42-CAF®09b vaccines in patients with locally advanced prostate cancerSofie Kirial Mørk, Per Kongsted, Marie Christine Wulff Westergaard, et al.
Cancer Letters|April 24, 2004
Role of glutathione in the induction of apoptosis and c-fos and c-jun mRNAs by oxidative stress in tumor cellsCarmen Tormos, F Javier Chaves, Maria José Garcia, et al.
Oncoimmunology|July 4, 2012
TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patientsPia Kvistborg, Chengyi Jenny Shu, Bianca Heemskerk, et al.
Annals of Surgical Oncology|April 24, 2019
A Combination of Positive Tumor HLA-I and Negative PD-L1 Expression Provides an Immune Rejection Mechanism in Bladder CancerJosé Francisco Flores-Martín, Francisco Perea, Manuela Exposito-Ruiz, et al.
International Journal of Cancer|October 4, 2011
Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon-mediated rejection genesRafael Carretero, Ena Wang, Ana I Rodriguez, et al.
International Journal of Cancer|June 21, 2013
Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanomaAna B del Campo, Jon Amund Kyte, Javier Carretero, et al.
Cancer Immunology, Immunotherapy : CII|December 14, 2004
High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosityTeresa Rodriguez, Rosa Méndez, Chrissy H Roberts, et al.
Oncotarget|February 10, 2018
HLA class I loss and PD-L1 expression in lung cancer: impact on T-cell infiltration and immune escapeFrancisco Perea, Abel Sánchez-Palencia, Mercedes Gómez-Morales, et al.
Pageof 25